Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients

NCT05395429 is registered in ClinicalTrials.gov with Genetron Health as lead sponsor.

NCT NCT05395429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05395429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients
Lead sponsor
Genetron Health
Phase
Observational
Overall status
Unknown status
Start date
March 25, 2022
Completion date
December 15, 2023
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer